Boston Scientific Corp (BSX)

88.95 +0.29 (+0.33%) USD  |  NYSE  |  Dec 20, 16:00
88.76 -0.19 (-0.21%) Pre-Market: 20:00
More

Boston Scientific Max Drawdown (5Y): 43.49% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for BSX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Baxter International Inc 64.18%
Haemonetics Corp 68.62%
ResMed Inc 53.98%
Globus Medical Inc 47.91%
Abbott Laboratories 33.88%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) 2.833
Beta (5Y) 0.8020
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 24.53%
Historical Sharpe Ratio (5Y) 0.5522
Historical Sortino (5Y) 0.705
Monthly Value at Risk (VaR) 5% (5Y Lookback) 9.54%